Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days-Reference-Cited by-同舟云学术

Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

Published:2024-05-03 Issue:7 Volume:69 Page:2540-2547
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Ding Yu-Ming,Duan Miao,Han Zhong-Xue,Song Xiao-Hui,Zhang Feng-Lan,Wang Zhi,Ning Zhang,Zeng Shu-yan,Kong Qing-Zhou,Zhang Wen-Lin,Liu Jing,Wan Meng,Lin Min-Juan,Lin Bo-Shen,Nan Xue-ping,Wang Hui,Li Yue-Yue,Zuo Xiu-Li,Li Yan-Qing

Funder

National Natural Science Foundation of China

National Clinical Research Center for Digestive Diseases supporting technology project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10620-024-08460-3.pdf

Reference34 articles.

1. Ren S, Cai P, Liu Y et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022;37:464–470. https://doi.org/10.1111/jgh.15751.

2. Xia C, Dong X, Li H et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135:584–590. https://doi.org/10.1097/cm9.0000000000002108.

3. Liu WZ, Xie Y, Lu H et al. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23:e12475. https://doi.org/10.1111/hel.12475.

4. Malfertheiner P, Megraud F, O’Morain CA et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6–30. https://doi.org/10.1136/gutjnl-2016-312288.

5. Liou JM, Malfertheiner P, Lee YC et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020;69:2093–2112. https://doi.org/10.1136/gutjnl-2020-322368.